Español
PrintEmail
Decrease (-) Restore Default Increase (+)
In This Section Texas Health Research & Education Institute

Clinical Trials

Disease or Condition   Breast Cancer
Title   Prospective Registry Of MammaPrint in Breast Cancer Patients with an Intermediate Recurrence Score (PROMIS)
Description   This will be a prospective observational, case-only, study of MammaPrint in patients with an
Oncotype DX intermediate score (18-30).
IRB Number   Pro3741
Inclusion/Notes   INCLUSION:
  • Women with histologically proven invasive stage I-II, node negative, hormone receptor positive, Her2 negative breast cancer, who received an Oncotype DX intermediate score (18-30).

  • = 18 years of age at time of consent.

  • Written informed consent.

EXCLUSION:
  • Insufficient tissue remaining for Mammaprint FFPE.

  • Tumor sample shipped to Agendia with = 30% tumor cells or that fails QA or QC criteria.

  • Women who have started or completed adjuvant chemotherapy or neo-adjuvant chemotherapy.
Status   Recruiting
Location   Texas Health Presbyterian Hospital Dallas
Principal Name    Ruben Augusto Saez MD
Contact Name   Lee Knox
Phone   (972) 739-3089

Online Tools

Locations

Helpful Info

Links